NCT00077441View on ClinicalTrials.gov

Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2006

Conditions
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver CancerRecurrent Adult Primary Liver Cancer
Interventions
DRUG

bortezomib

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

55905

Mayo Clinic, Rochester

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00077441 - Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer) | Biotech Hunter | Biotech Hunter